Evidence map›Paper›PMID 11141488›Full record

ArticleThe American journal of pathology2001

Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation.

G Matute-Bello, R K Winn, M Jonas, E Y Chi, T R Martin, W C Liles

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 246 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Bioactive Constituents ofInternational journal of molecular sciences · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

G Matute-BelloDivisions of Pulmonary and Critical Care Medicine, University of Washington, Seattle 98195, USA.
R K Winn
M Jonas
E Y Chi
T R Martin
W C Liles
University of Washington · US

Funding

TLR activation of Rho GTPase regulated signaling pathwayP01GM037696 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 1987 to 2006
$9.0M
TOXIC OXYGEN PRODUCTS AND PULMONARY EDEMAP50HL030542 · NHLBI · UNIVERSITY OF WASHINGTON · PI HUDSON, LEONARD D · 1985 to 2003
$6.1M
PHAGOCYTE FAS/FASL SYSTEM IN ACUTE INFLAMMATIONR01HL062995 · NHLBI · UNIVERSITY OF WASHINGTON · PI LILES, W. CONRAD · 2000 to 2004
$1.1M
ALVEOLAR MACROPHAGE-DERIVED NEUTROPHIL CHEMOATTRACTANTR01AI029103 · NIAID · UNIVERSITY OF WASHINGTON · PI MARTIN, THOMAS R · 1990 to 1998
–
NHLBI NIH HHS HL 30542NHLBI NIH HHS R01 HL062995NIAID NIH HHS AI 29103NIGMS NIH HHS P01 GM037696PHS HHS GR 42686
6 · The paper itself

Abstract

Activation of the Fas/FasL system induces apoptosis of susceptible cells, but may also lead to nuclear factor kappaB activation. Our goal was to determine whether local Fas activation produces acute lung injury by inducing alveolar epithelial cell apoptosis and by generating local inflammatory responses. Normal mice (C57BL/6) and mice deficient in Fas (lpr) were treated by intranasal instillation of the Fas-activating monoclonal antibody (mAb) Jo2 or an irrelevant control mAb, and studied 6 or 24 hours later using bronchoalveolar lavage (BAL), histopathology, DNA nick-end-labeling assays, and electron microscopy. Normal mice treated with mAb Jo2 had significant increases in BAL protein at 6 hours, and BAL neutrophils at 24 hours, as compared to lpr mice and to mice treated with the irrelevant mAb. Neutrophil recruitment was preceded by increased mRNA expression for tumor necrosis factor-alpha, macrophage inflammatory protein-1alpha, macrophage inflammatory protein-2, macrophage chemotactic protein-1, and interleukin-6, but not interferon-gamma, transforming growth factor-ss, RANTES, eotaxin, or IP-10. Lung sections from Jo2-treated normal mice showed neutrophilic infiltrates, alveolar septal thickening, hemorrhage, and terminal dUTP nick-end-labeling-positive cells in the alveolar septae and airspaces. Type II pneumocyte apoptosis was confirmed by electron microscopy. Fas activation in vivo results in acute alveolar epithelial injury and lung inflammation, and may be important in the pathogenesis of acute lung injury.

Indexed as

ApoptosisAcute DiseaseAnimalsAntibodies, MonoclonalBronchoalveolar Lavage FluidCytokinesEpithelial CellsFas Ligand Proteinfas ReceptorGene ExpressionLeukocyte CountLungMembrane GlycoproteinsMiceMice, Inbred C57BLMice, Mutant StrainsAntibodies, MonoclonalCytokinesFas Ligand ProteinFasl protein, mousefas ReceptorMembrane GlycoproteinsRNA, Messenger

Identifiers

PMID11141488
PMCPMC1850249
OpenAlexW1560596088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.